| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |